Beef cows supplemented with RPM (HMA) during pre and postpartum did not show improvement in BW and BCS at any time point when compared to the non-supplemented cows ( Finally, it is important to mention that despite the lack of differences between RPM and control-treated cows, clear changes were reported regarding maternal blood parameters, nutrient delivery through the placenta, in addition to positive effects on follicular and fetal development, and offsprings postnatal performance
#GLP1 #Noom #ObesityTreatment #DigitalHealth #WeightLoss #Semaglutide #HealthTech #CompoundedDrugs #PharmaInnovation #BehavioralHealth To view or add a comment, sign in More Relevant Posts #MIMSPharmaMarketInsightUpdate, September 2025 Including: SGLT2 inhibitors should be offered first-line to people with heart failure with reduced ejection fraction A new formulation of Rybelsus (semaglutide) tablets has been released The first inhaled levodopa product, Inbrija (levodopa), has been launched
Comparisons typically focus on: Molecular stability Research model applications Differences in signalling pathways These comparisons are academic in nature and do not imply superiority, effectiveness, or suitability for human use
Williams did an amazing job
Recalls & Warnings November 21, 2013 FDA Warns of Five More Weight Loss Supplements Containing Undeclared Drugs On November 21, 2013, the FDA warned consumers not to buy or use the following weight loss supplements because they were found to contain one or both of the undeclared drugs sibutramine and phenolphthalein: Recalls & Warnings December 12, 2014 Marketers of HCG Settle FTC Charges of Deceptive Weight Loss Claims Marketers of HCG Platinum drops have agreed to pay $1 million to settle Federal Trade Commission (FTC) charges that claims the drops could cause rapid and substantial weight loss were deceptive and not supported by scientific evidence